Metis TechBio Signs Up to $1.1 Billion Deal With Eli Lilly
Metis TechBio said it entered a collaboration agreement with Eli Lilly for research and development of tissue-specific drug delivery technologies. The deal is worth up to $1.1 billion.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.